Inspirotec Appoints SVP of Tech & International Ops
CHICAGO, January 24, 2020 — Inspirotec Inc., is a rapidly growing Chicago-based company with its ExhaleTM highly portable whole house allergen measuring system and remediation support services. ExhaleTM is the only air quality system on the market with proprietary technology for measuring airborne bio-material uniquely targeted for consumers, allergists, indoor air quality experts, and for the home resale markets. The company is scaling up for expanded growth.
Ashwani Kumar brings nearly 35 years of experience in pharmaceuticals, medical devices and specialty chemicals in various technical and management leadership roles for entities such as Dow, Jubilant, Medreich, Bluefish, GeneriCo, Direct Rx Exchange. In his global roles, he has led the strategies and operations of manufacturing and R&D sites, international business of import/export, compliances with worldwide pharma regulatory and quality demands, licensing of products, and management of international customer base. He was responsible for successfully building effective India operations of various USA and European companies into a strong and integrated part Bluefish global business. His experience base includes sustained stints with large and start-up companies in multiple geographies.
In his role as SVP-Technical and International Operations of Inspirotec, Inc., Dr. Kumar will bring his depth and breadth of experience in formulations, bulk drug and medical devices manufacturing and R&D operations to lead and establish the technical and quality systems, infrastructure, Supply Chain Management, and international presence based out of India.
“I look forward to working with the talented Inspirotec Team and making contributions in achieving new levels of success.” said Ashwani Kumar
About Inspirotec Inc.
Inspirotec Inc is the only company providing airborne allergen detection either through physicians, industrial hygienists, indoor air quality
professionals, home resale, or direct to consumer. Direct to consumer is marketed under the brand name Exhale and can be purchased
Inspirotec has an extensive portfolio of patents* as well as publications in the peer-reviewed literature1-4 *US patents 8,038,944, 9,216,421, 9,360,402, 9,481,904, 9,618,431 as well as patents and application worldwide. 1Gordon J, Detjen P, Nimmagadda S, Rogers L, Patel S, Thompson J, Reboulet R and Gandhi P. Bedroom exposure to airborne allergens in the Chicago area using a patient-operated sampling device. Ann Allergy Asthma Immunol. 2018;121(1):211-220. 2Gordon J, Gandhi P, Shekhawat G, Frazier A, Hampton-Marcell J, Gilbert JA. A simple novel device for air sampling by electrokinetic capture. Microbiome. 2015;3. 3Gordon J, Detjen P, Kelso D, Gandhi P. A new patient-operated sampling device for measurement of aeroallergens. Ann Allergy Asthma Immunol. 2016;116(5):475-6. 4Gordon J, Reboulet R, Gandhi P, Matsui E. Validation of a novel sampling technology for airborne allergens in low-income urban homes. Ann Allergy Asthma Immunol. 2018;120(1):96-97. 5Richardson M, Gottel N, Gilbert J, Gordon J, Gandhi P, Reboulet R Hampton-Marcell J. Concurrent measurement of microbiome and allergens in the air of bedrooms of allergy disease patients in the Chicago area. Microbiome 2019;7:82
Latest posts by Katie Gragg (see all)
- Inspirotec Appoints SVP of Tech & International Ops - January 24, 2020
- Researchers Consider The Link Between Air Pollution and DNA - January 16, 2020
- Inspirotec to Present at AAAAI 2020 Annual Meeting - November 26, 2019